CMPS - COMPASS Pathways plc Stock Price and Quote

CMPS | COMPASS Pathways plc | [NASD]

Healthcare | Medical Care Facilities | United Kingdom

Index	-	P/E	-	EPS (ttm)	-2.22	Insider Own	45.42%	Shs Outstand	42.73M	Perf Week	-5.09%
Market Cap	341.27M	Forward P/E	-	EPS next Y	-2.53	Insider Trans	0.00%	Shs Float	25.03M	Perf Month	-5.32%
Income	-94.50M	PEG	-	EPS next Q	-0.68	Inst Own	18.40%	Short Float / Ratio	10.89% / 10.16	Perf Quarter	-9.14%
Sales	-	P/S	-	EPS this Y	-20.20%	Inst Trans	2.60%	Short Interest	2.73M	Perf Half Y	-27.00%
Book/sh	3.78	P/B	2.02	EPS next Y	1.20%	ROA	-45.40%	Target Price	42.30	Perf Year	-1.54%
Cash/sh	2.62	P/C	2.91	EPS next 5Y	-	ROE	-49.60%	52W Range	6.97 - 21.50	Perf YTD	-4.73%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-64.42%	Beta	-
Dividend %	-	Quick Ratio	14.90	Sales past 5Y	-	Gross Margin	-	52W Low	9.76%	ATR	0.45
Employees	114	Current Ratio	14.90	Sales Q/Q	-	Oper. Margin	-	RSI (14)	37.61	Volatility	5.59% 5.20%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-12.50%	Profit Margin	-	Rel Volume	0.66	Prev Close	7.48
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 11 BMO	Payout	-	Avg Volume	268.19K	Price	7.65
Recom	1.60	SMA20	-6.38%	SMA50	-15.47%	SMA200	-27.38%	Volume	178,040	Change	2.27%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-21-22	Resumed	Berenberg	Buy	$33
Nov-01-22	Initiated	Loop Capital	Buy	$34
Oct-29-21	Initiated	Oppenheimer	Outperform	$50
Jul-13-21	Initiated	Citigroup	Buy	$67
Jun-28-21	Initiated	Maxim Group	Buy	$70
May-11-21	Initiated	Cantor Fitzgerald	Overweight	$71
Apr-01-21	Initiated	ROTH Capital	Buy	$88
Oct-14-20	Initiated	H.C. Wainwright	Buy	$65
Oct-13-20	Initiated	Evercore ISI	Outperform
Oct-13-20	Initiated	Cowen	Outperform
Oct-13-20	Initiated	Canaccord Genuity	Buy	$80
Oct-13-20	Initiated	Berenberg	Buy	$50

Show Previous Ratings

May-26-23 04:00PM	COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference (GlobeNewswire)
07:00AM	Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023 (GlobeNewswire)
May-11-23 12:30PM	Compass Pathways Plc (CMPS) Q1 2023 Earnings Call Transcript (Motley Fool)
07:00AM	COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
May-06-23 09:37AM	This Regulatory Change Means Psychedelic Stocks Are One Step Closer to Being a Buy. Here's Why (Motley Fool)
04:01PM	Loading…
May-03-23 04:01PM	COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023 (GlobeNewswire)
May-02-23 07:00AM	American Medical Association to Issue First New Code for Psychedelic Therapies (GlobeNewswire)
Apr-20-23 08:55AM	After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy? (Motley Fool)
Apr-10-23 10:10AM	COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-12-23 12:22PM	10 Best Psychedelic Stocks to Buy According to Hedge Funds (Insider Monkey)
Mar-06-23 08:50AM	2 Potentially Explosive Growth Stocks Down 30% or More to Buy for the Next Bull Market (Motley Fool)
08:30AM	2 Growth Stocks With Incredible Potential in the Next 5 Years (Motley Fool)
Mar-02-23 10:23AM	COMPASS Pathways to participate in upcoming Cowen 43rd Annual Health Care Conference, Oppenheimer 33rd Annual Healthcare Conference, and Loop Capital Investor Conference (GlobeNewswire) +5.17%
07:07AM	COMPASS Pathways plc (NASDAQ:CMPS) Q4 2022 Earnings Call Transcript (Insider Monkey)
12:00AM	Anorexia is the deadliest psychiatric disorder. Could psychedelics help? (Financial Times)
12:12AM	Loading…
Mar-01-23 12:12AM	Q4 2022 Compass Pathways PLC Earnings Call (Thomson Reuters StreetEvents)
Feb-28-23 02:00PM	Compass Pathways Plc (CMPS) Q4 2022 Earnings Call Transcript (Motley Fool)
07:00AM	COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results and Business Highlights (GlobeNewswire)
Feb-24-23 12:01PM	COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023 (GlobeNewswire)
Feb-12-23 02:21PM	7 Long-Term Stocks to Buy With Your Tax Refund (InvestorPlace)
Feb-07-23 05:52AM	3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street (Motley Fool)
Feb-06-23 08:28PM	7 Tempting Sin Stocks to Buy for Promising Profits (InvestorPlace)
Feb-05-23 02:30PM	The 7 Most Promising Psychedelic Stocks to Buy in February (InvestorPlace)
Jan-27-23 09:40AM	Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jan-13-23 12:00PM	All You Need to Know About COMPASS Pathways PLC Sponsored ADR (CMPS) Rating Upgrade to Strong Buy (Zacks)
Jan-11-23 09:40AM	Are Medical Stocks Lagging COMPASS Pathways (CMPS) This Year? (Zacks) +5.69%
Dec-08-22 04:00AM	COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP (GlobeNewswire) -7.24%
Nov-29-22 10:00AM	3 Big Trends Shaking Up Psychedelic Stocks (Motley Fool)
Nov-28-22 04:01PM	COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference (GlobeNewswire) -6.07%
Nov-04-22 12:16PM	REFILE-Magic mushroom compound shows promise as depression treatment in key study (Reuters)
01:00PM	Loading…
Nov-03-22 01:00PM	COMPASS Pathways plc (CMPS) Q3 2022 Earnings Call Transcript (Motley Fool)
07:00AM	COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights (GlobeNewswire)
06:00AM	COMPASS Pathways announces publication of phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression in The New England Journal of Medicine (GlobeNewswire)
Nov-02-22 05:10PM	Magic mushrooms study finds significant effect on depression (Financial Times) -7.98%
05:00PM	REFILE-Magic mushroom compound shows promise as depression treatment in key study (Reuters)
05:00PM	Magic mushroom compound shows promise as depression treatment in key study (Reuters)
Oct-29-22 09:50AM	COMPASS Pathways plc's (NASDAQ:CMPS) market cap increased by US$60m, insiders receive a 33% cut (Simply Wall St.)
Oct-26-22 04:00PM	COMPASS Pathways plc to announce third quarter 2022 financial results on 3 November 2022 (GlobeNewswire)
Oct-25-22 12:00PM	COMPASS Pathways PLC Sponsored ADR (CMPS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) +6.24%
Oct-12-22 11:00AM	COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in Treatment Resistant Depression at Capital Markets Day (GlobeNewswire) -7.71%
Oct-04-22 09:05AM	COMPASS Pathways to Hold Virtual Capital Market Day on 12 October 2022 (GlobeNewswire) +8.75%
Sep-28-22 10:30AM	2 No-Brainer Stocks to Buy Right Now for Less Than $15 (Motley Fool)
Sep-27-22 08:36AM	Is Now a Good Time to Invest In Psychedelics Stocks? (Motley Fool) +5.30%
Sep-19-22 04:01PM	COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit (GlobeNewswire)
Sep-12-22 05:30AM	Investors Bet Ketamine Treatment Will Revolutionize Mental-Health Care (WSJ)
Sep-09-22 10:37AM	Buying These 2 Battered Growth Stocks Right Now Could Be Brilliant (Motley Fool)
Sep-05-22 10:45AM	2 Top Trends to Invest $2,000 in Ahead of the Crowd (Motley Fool)
Sep-01-22 08:06AM	COMPASS Pathways to participate in three upcoming investor events (GlobeNewswire)
Aug-30-22 03:02PM	7 Psychedelics Stocks to Buy for a Big Drug Boom (InvestorPlace) -8.18%
Aug-25-22 04:41PM	Why Compass Pathways Stock Blasted Higher This Week (Motley Fool)
Aug-21-22 10:27AM	3 Stocks to Buy and Hold for the Long Term (Motley Fool)
Aug-20-22 08:03AM	We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth (Simply Wall St.)
Aug-16-22 03:40PM	These Depression Players Are Top Picks For $400B Mental Healthcare Market, Says Analyst (Benzinga)
Aug-09-22 09:43PM	3 Best Psychedelic Stocks to Buy Now (InvestorPlace)
Aug-08-22 09:55AM	Wall Street Analysts See a 289% Upside in COMPASS Pathways PLC Sponsored ADR (CMPS): Can the Stock Really Move This High? (Zacks)
Aug-04-22 07:30PM	COMPASS Pathways plc (CMPS) Q2 2022 Earnings Call Transcript (Motley Fool) +9.10%
07:00AM	COMPASS Pathways plc announces second quarter 2022 financial results and business highlights (GlobeNewswire)
Aug-02-22 04:05PM	COMPASS Pathways Announces Grant of Inducement Award for Newly Appointed Chief Executive Officer Pursuant to Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.49%
Aug-01-22 08:00AM	COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord Annual Growth Conference (GlobeNewswire)
Jul-28-22 04:00AM	COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa (GlobeNewswire)
Jul-26-22 08:00AM	COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022 (GlobeNewswire)
Jul-19-22 08:00AM	COMPASS Pathways appoints Kabir Nath as Chief Executive Officer (GlobeNewswire)
Jun-03-22 09:55AM	Wall Street Analysts See a 781% Upside in COMPASS Pathways PLC Sponsored ADR (CMPS): Can the Stock Really Move This High? (Zacks)
May-23-22 07:00AM	COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting (GlobeNewswire)
May-22-22 09:26AM	Could The COMPASS Pathways plc (NASDAQ:CMPS) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
May-12-22 08:00AM	COMPASS Pathways to participate in upcoming Citis Biopharma Virtual Co-Panel Day and H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-10-22 12:30PM	COMPASS Pathways plc (CMPS) Q1 2022 Earnings Call Transcript (Motley Fool) +11.41%
07:00AM	COMPASS Pathways plc announces first quarter 2022 financial results and business highlights (GlobeNewswire)
May-09-22 07:00AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -11.33%
07:00AM	COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults (GlobeNewswire)
May-03-22 08:00AM	COMPASS Pathways plc to announce first quarter 2022 financial results on 10 May 2022 (GlobeNewswire)
07:00AM	COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression (GlobeNewswire)
Apr-20-22 07:00AM	COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers (GlobeNewswire)
Apr-19-22 08:07AM	Interested in Investing in Psychedelics? Check Out This Podcast. (Motley Fool)
Apr-12-22 12:44PM	Magic mushrooms are turning into big business (The Telegraph)
Apr-04-22 08:00AM	COMPASS Pathways to participate in Needham Healthcare conference (GlobeNewswire) +6.06%
Mar-24-22 05:00AM	COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK (GlobeNewswire)
Mar-02-22 07:00AM	COMPASS Pathways to participate in Cowen and Roth investor conferences (GlobeNewswire)
Feb-24-22 07:30PM	COMPASS Pathways plc (CMPS) Q4 2021 Earnings Call Transcript (Motley Fool)
07:12AM	COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business highlights (GlobeNewswire)
Feb-17-22 12:21PM	COMPASS Pathways plc to announce fourth quarter and full year 2021 financial results on 24 February 2022 (GlobeNewswire) -5.75%
07:00AM	Why the Stock Market Is a Terrible Thermometer of Biotech Success (Motley Fool)
Jan-19-22 07:00AM	Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant depression (GlobeNewswire)
Jan-10-22 07:00AM	COMPASS Pathways to participate in H.C. Wainwright investor conference (GlobeNewswire)
Jan-04-22 07:00AM	COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (GlobeNewswire) -5.90%
Dec-23-21 06:48AM	The Zacks Analyst Blog Highlights: PSY, PSIL, Atai Life Sciences, COMPASS Pathways and Field Trip Health (Zacks)
Dec-22-21 01:43PM	3 Psychedelic Stocks to Play the Shroom Boom (Zacks)
Dec-17-21 07:00AM	COMPASS Selected for Addition to NASDAQ Biotechnology Index (GlobeNewswire)
Dec-16-21 07:40AM	COMPASS Pathways announces changes in Executive Team (GlobeNewswire) -5.18%
Dec-13-21 07:00AM	COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study (GlobeNewswire)
05:21AM	What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry? (Simply Wall St.)
Dec-08-21 06:48PM	Analyst Sees Huge Upside for These 2 Strong Buy Psychedelic Stocks (TipRanks)
Dec-06-21 07:01AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -7.43%
Dec-03-21 07:00AM	Michael Falvey joins COMPASS Pathways as Chief Financial Officer (GlobeNewswire) -7.36%
Dec-01-21 07:00AM	COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression (GlobeNewswire)
Nov-30-21 08:00AM	COMPASS Pathways to participate in upcoming Evercore, H.C. Wainwright & Berenberg investor conferences (GlobeNewswire)
Nov-29-21 07:00AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Nov-28-21 07:17AM	Were Compass Pathways' Clinical Trial Results Really That Bad? (Motley Fool)
Nov-23-21 07:00AM	COMPASS Pathways granted fifth US patent for crystalline psilocybin (GlobeNewswire)
Nov-21-21 06:45AM	Better Buy: Compass Pathways vs. Jazz Pharmaceuticals (Motley Fool)

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience